Beam Therapeutics Inc. Q3 Loss Misses Estimates
(RTTNews) - Beam Therapeutics Inc. (BEAM) reported Loss for third quarter that missed the Street estimates.
The company's earnings came in at -$96.668 million, or -$1.17 per share. This compares with -$96.088 million, or -$1.22 per share, in last year's third quarter.
Analysts on average had expected the company to earn -$1.16 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter fell 17.0% to $14.269 million from $17.193 million last year.
Beam Therapeutics Inc. earnings at a glance (GAAP) :
-Earnings (Q3): -$96.668 Mln. vs. -$96.088 Mln. last year. -EPS (Q3): -$1.17 vs. -$1.22 last year. -Revenue (Q3): $14.269 Mln vs. $17.193 Mln last year.
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.